/
PLRZ
$10.75+$1.03 (+10.60%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$20.3M
2M shares
52-week range
$2.88 – $18.20
51% from low
Exchange
NASDAQ
CS
Change$-2314.25
Polyrizon Ltd. Ordinary Shares
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
www.polyrizon-biotech.com- Employees
- 1
- IPO / List date
- Oct 29, 2024
Held by traders on TradeandTell
No one on the platform currently holds PLRZ.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PLRZ as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-11-28 | 1-for-6reverse |
| 2025-05-27 | 1-for-250reverse |
Recent trades on TradeandTell
No one on the platform has traded PLRZ yet.
